Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol

Vaccine

Volumn 31, Issue 16, 2013, Pages 2080-2088

  Prymula, Roman ^a   Habib, Ahsan ^b   François, Nancy ^b   Borys, Dorota ^b   Schuerman, Lode ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b GSK   (Belgium)

Author keywords

Antibody persistence; Immunological memory; Nasopharyngeal carriage; Prophylactic paracetamol; Streptococcus pneumoniae; Vaccine

Indexed keywords

PARACETAMOL; PNEUMOCOCCUS VACCINE;

ANOREXIA; ARTICLE; CHILD; CONTROLLED STUDY; DROWSINESS; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL CARRIAGE; NEISSERIA MENINGITIDIS; PAIN; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SEROTYPE; SIDE EFFECT; SKIN REDNESS; SWELLING;

ACETAMINOPHEN; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINATION; VACCINES, CONJUGATE;

EID: 84875530914     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.044     Document Type: Article

References (25)

1. Klein Klouwenberg P., Bont L. Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines. Clin Dev Immunol 2008, 2008:628963.
2. Silfverdal S.A., Hogh B., Bergsaker M.R., Skerlikova H., Lommel P., Borys D., et al. Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcocal non-typeable Haemophilus influenzae protein D conjugate vaccine. Pediatr Infect Dis J 2009, 28(10):e276-e282.
3. Wysocki J., Tejedor J.C., Grunert D., Konior R., Garcia-Sicilia J., Knuf M., et al. Immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines. Pediatr Infect Dis J 2009, 28(4 Suppl.):S77-S88.
4. Knuf M., Szenborn L., Moro M., Petit C., Bermal N., Bernard L., et al. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Pediatr Infect Dis J 2009, 28(4):S97-S108.
5. Vesikari T., Karvonen A., Lindblad N., Korhonen T., Lommel P., Willems P., et al. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months. Pediatr Infect Dis J 2010, 29(6):e47-e56.
6. Bermal N., Szenborn L., Alberto E., Hernandez M., Pejcz J., Majda-Stanislawska E., et al. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines. Pediatr Infect Dis J 2011, 30(1):69-72.
7. Lagos R.M., Muñoz A.E., Levine M.M., Lepetic A., François N., Yarzabal J.P., et al. Safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Chilean children. Hum Vaccin 2011, 7(5):511-522.
8. Kim C.H., Kim J.S., Cha S.H., Kim K.N., Kim J.D., Lee K.Y., et al. Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in Korean infants. Pediatr Infect Dis J 2011, 30(12):e235-e243.
9. Silfverdal S.A., Skerlikova H., Zanova M., Papúchová D., Traskine M., Borys D., et al. Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2 dose or 3 dose priming and a booster dose in the first year of life. Pediatr Infect Dis J 2011, 30(9):e155-e163.
10. Knuf M., Pankow-Culot H., Grunert D., Rapp M., Panzer F., Köllges R., et al. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants. Pediatr Infect Dis J 2012, 31(1):e31-e36.
11. Vu H.T., Yoshida L.M., Suzuki M., Nguyen H.A., Nguyen C.D., Nguyen A.T., et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011, 30(1):11-18.
12. Syrjänen R.K., Auranen K.J., Leino T.M., Kilpi T.M., Mäkelä P.H. Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J 2005, 24(9):801-806.
13. World Health Organization (WHO) Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007, 82:93-104.
14. Prymula R., Hanovcova I., Splino M., Kriz P., Motlova J., Lebedova V., et al. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine 2011, 29(10):1959-1967.
15. Prymula R., Siegrist C.A., Chlibek R., Zemlickova H., Vackova M., Smetana J., et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009, 374(9698):1339-1350.
16. Concepcion N., Frasch C. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2001, 8(2):266-272.
17. Henckaerts I., Goldblatt D., Ashton L., Poolman J. Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera. Clin Vaccine Immunol 2006, 13(3):356-360.
18. Poolman J.T., Frasch C.E., Käyhty H., Lestrate P., Madhi S.A., Henckaerts I. Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol 2010, 17(1):134-142.
19. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., Whitin J.C., et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997, 4(4):415-422.
20. Murray P.R., Baron E.J., Jorgensen J.H., Landry M.L., Pfaller M.A. Manual of clinical microbiology 2007, American Society for Microbiology, Washington, DC. 9th ed.
21. Murphy T.F., Brauer A.L., Sethi S., Kilian M., Cai X., Lesse A.J. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J Infect Dis 2007, 195(1):81-89.
22. Frasch C.E. Haemophilus influenza type b conjugate and combination vaccines. Clin Immunother 1995, 4(5):376-386.
23. Rose M.A., Schubert R., Strnad N., Zielen S. Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine. Clin Diagn Lab Immunol 2005, 12(10):1216-1222.
24. Cheung Y.B., Zaman S.M., Nsekpong E.D., Van Beneden C.A., Adegbola R.A., Greenwood B., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 2009, 28(11):990-995.
25. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007, 196(8):1211-1220.